PCSK9 inhibitors and ezetimibe for the reduction of cardiovascular events: a clinical practice guideline with risk-stratified recommendations
Published 2022 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
PCSK9 inhibitors and ezetimibe for the reduction of cardiovascular events: a clinical practice guideline with risk-stratified recommendations
Authors
Keywords
-
Journal
BMJ-British Medical Journal
Volume -, Issue -, Pages e069066
Publisher
BMJ
Online
2022-05-05
DOI
10.1136/bmj-2021-069066
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Safety of proprotein convertase subtilisin/kexin 9 inhibitors: a systematic review and meta-analysis
- (2022) Jing Li et al. HEART
- PCSK9 inhibitors and ezetimibe with or without statin therapy for cardiovascular risk reduction: a systematic review and network meta-analysis
- (2022) Safi U Khan et al. BMJ-British Medical Journal
- Statin treatment and muscle symptoms: series of randomised, placebo controlled n-of-1 trials
- (2021) Emily Herrett et al. BMJ-British Medical Journal
- 2021 Canadian Cardiovascular Society Guidelines for the Management of Dyslipidemia for the Prevention of Cardiovascular Disease in the Adult
- (2021) Glen J. Pearson et al. CANADIAN JOURNAL OF CARDIOLOGY
- Side Effect Patterns in a Crossover Trial of Statin, Placebo, and No Treatment
- (2021) James P. Howard et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Values, preferences and burden of treatment for the initiation of GLP-1 receptor agonists and SGLT-2 inhibitors in adult patients with type 2 diabetes: a systematic review
- (2021) José Gerardo González-González et al. BMJ Open
- Perceptions of injectable therapies with cardiovascular benefit: an ACNAP survey of healthcare professionals to explore facilitators and barriers
- (2021) Rani Khatib et al. European Journal of Cardiovascular Nursing
- Incidence and Predictors of Major Adverse Cardiovascular Events in Patients With Established Atherosclerotic Disease or Multiple Risk Factors
- (2020) Benjamin Miao et al. Journal of the American Heart Association
- The Role of Statins in Current Guidelines
- (2020) Fabiana Rached et al. Current Atherosclerosis Reports
- An integrative review on facilitators and barriers in delivering and managing injectable therapies in chronic conditions: A part of the ACNAP project ‘injectable medicines among patients with cardiovascular conditions’
- (2020) Ekaterini Lambrinou et al. European Journal of Cardiovascular Nursing
- A framework for practical issues was developed to inform shared decision-making tools and clinical guidelines
- (2020) Anja Fog Heen et al. JOURNAL OF CLINICAL EPIDEMIOLOGY
- N-of-1 Trial of a Statin, Placebo, or No Treatment to Assess Side Effects
- (2020) Frances A. Wood et al. NEW ENGLAND JOURNAL OF MEDICINE
- Cost-Effectiveness of Alirocumab
- (2019) Dhruv S. Kazi et al. ANNALS OF INTERNAL MEDICINE
- 2018 AHA/ACC/AACVPR/AAPA/ABC/ACPM/ADA/AGS/APhA/ASPC/NLA/PCNA Guideline on the Management of Blood Cholesterol
- (2019) Scott M. Grundy et al. CIRCULATION
- Proprotein convertase subtilisin/kexin 9 inhibitors in reducing cardiovascular outcomes: a systematic review and meta-analysis
- (2019) Heyue Du et al. HEART
- Updated Cost-effectiveness Analysis of Evolocumab in Patients With Very High-risk Atherosclerotic Cardiovascular Disease
- (2019) Gregg C. Fonarow et al. JAMA Cardiology
- 2019 ESC/EAS Guidelines for the management of dyslipidaemias: lipid modification to reduce cardiovascular risk
- (2019) François Mach et al. EUROPEAN HEART JOURNAL
- Statins for primary prevention of cardiovascular disease
- (2019) Paula Byrne et al. BMJ-British Medical Journal
- Cardiovascular disease risk prediction equations in 400 000 primary care patients in New Zealand: a derivation and validation study
- (2018) Romana Pylypchuk et al. LANCET
- A Bayesian network meta-analysis of PCSK9 inhibitors, statins and ezetimibe with or without statins for cardiovascular outcomes
- (2018) Safi U Khan et al. European Journal of Preventive Cardiology
- Introduction toBMJRapid Recommendations
- (2016) Reed A Siemieniuk et al. BMJ-British Medical Journal
- Introduction toBMJRapid Recommendations
- (2016) Reed A Siemieniuk et al. BMJ-British Medical Journal
- Estimated 10-year cardiovascular mortality seriously underestimates overall cardiovascular risk
- (2015) Harald T Jørstad et al. HEART
- GRADE guidelines: 15. Going from evidence to recommendation—determinants of a recommendation's direction and strength
- (2013) Jeffrey C. Andrews et al. JOURNAL OF CLINICAL EPIDEMIOLOGY
- Going from evidence to recommendations
- (2008) Gordon H Guyatt et al. BMJ-British Medical Journal
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started